Deprescribing in migraine

Expert Opin Drug Saf. 2021 Jun;20(6):623-625. doi: 10.1080/14740338.2021.1907342. Epub 2021 Mar 25.

Authors

Paolo Martelletti^{1

2}, Michelangelo Luciani², Valerio Spuntarelli², Enrico Bentivegna²

Affiliations

¹ Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
² Emergency Medicine Unit, Regional Referral Headache Center, Sant'Andrea University Hospital, Rome, Italy.

PMID: 33749470
DOI: 10.1080/14740338.2021.1907342

No abstract available

Keywords: CGRP(r) monoclonal antibodies; combination therapy; ditans; drug–drug interactions; gepants; migraine; onabotulinumtoxin-A.

Publication types

Editorial

MeSH terms

Deprescriptions*
Disabled Persons
Drug Therapy, Combination
Humans
Migraine Disorders / drug therapy*
Migraine Disorders / physiopathology